alexa
Reach Us +441467840001
Neurogenin-2–transduced Human Neural Progenitor Cells Attenuate Neonatal Hypoxic-ischemic Brain Injury | 75135
ISSN: 2157-7552

Journal of Tissue Science & Engineering
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Neurogenin-2–transduced human neural progenitor cells attenuate neonatal hypoxic-ischemic brain injury

7th International Conference on Tissue Engineering & Regenerative Medicine

Kook In Park

Yonsei University College of Medicine, Korea

Posters & Accepted Abstracts: J Tissue Sci Eng

DOI: 10.4172/2157-7552-C1-040

Abstract
Neonatal hypoxic-ischemic (HI) brain injury leads to high mortality and neuro-developmental disorders. Multipotent neural progenitor cells (NPCs) with self-renewing capacity, have the potential to reduce neuronal loss and improve the compromised environment in the HI brain injury. However, the therapeutic efficacy of neuronal committed progenitor cells and the underlying mechanisms of recovery are not fully understood yet. Therefore, this study investigated the regenerative ability and action mechanisms of neuronally committed human NPCs (hNPCs) transduced with neurogenin-2 (NEUROG2) in neonatal HI brain injury. NEUROG2- or green fluorescent protein (GFP)–encoding adenoviral vector–transduced hNPCs (NEUROG2- or GFP-NPCs) were transplanted into neonatal mouse brains with HI injury. Grafted NEUROG2-NPCs showed robust dispersion and engraftment, prolonged survival, and neuronal differentiation in HI brain injury. NEUROG2-NPCs significantly improved neurological behaviors, decreased cellular apoptosis, and increased the neurite outgrowth and axonal sprouting in HI brain injury. In contrast, GFP-NPC grafts moderately enhanced axonal extension with limited behavioral recovery. Notably, NEUROG2-NPCs showed increased secretion of multiple factors, such as nerve growth factor, brainderived neurotrophic factor, neurotrophin-3 (NTF3), fibroblast growth factor 9 (FGF9), ciliary neurotrophic factor (CNTF), and thrombospondins 1 and 2 (THBS 1/2), which promoted SH-SY5Y neuroblastoma cell survival and neurite outgrowth. Thus, we postulate that NEUROG2-expressing human NPCs facilitate functional recovery after neonatal HI brain injury via their ability to secrete multiple factors that enhance neuronal survival and neuroplasticity.
Biography

Kook In Park has completed his MD and PhD from Yonsei University College of Medicine (YUMC) and Post-doctoral studies from Harvard Medical School, Boston. He is a Professor in the Department of Pediatrics and a Chief of Neonatology in Severance Children’s Hosptial, YUMC. He has published more than 200 papers in reputed clinical and basic biology journals and has been serving as an Editorial Board Member of repute.

Top